Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 43 | $1,034,337,950 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 100 | 184.17 | 18,417 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 200 | 182.625 | 36,525 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 200 | 181.365 | 36,273 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 307 | 180.2574 | 55,339 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 993 | 179.3276 | 178,072 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 1,801 | 178.0995 | 320,757 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 5,994 | 177.1106 | 1,061,601 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 13 Mar 2024 | Sale | 2,737 | 176.3476 | 482,663 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 200 | 169.05 | 33,810 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 733 | 166.4439 | 122,003 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 2,602 | 165.4876 | 430,599 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 12,069 | 164.4877 | 1,985,202 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 15,466 | 163.7793 | 2,533,011 | D |
14 Mar 2024 17:23 | BGNE | BeiGene Ltd. | OYLER JOHN | Chief Executive Officer | 12 Mar 2024 | Sale | 6,598 | 162.7378 | 1,073,744 | D |
04 Mar 2024 17:22 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 29 Feb 2024 | Sale | 397 | 167.08 | 66,331 | D |
14 Nov 2023 17:54 | BGNE | BeiGene Ltd. | BAKER BROS. ADVISORS LP | Director , 10% | 14 Nov 2023 | Sale | 1,008,660 | 180.5 | 182,063,130 | I |
14 Nov 2023 17:54 | BGNE | BeiGene Ltd. | BAKER BROS. ADVISORS LP | Director , 10% | 14 Nov 2023 | Sale | 91,340 | 180.5 | 16,486,870 | I |
02 Aug 2023 17:10 | BGNE | BeiGene Ltd. | LEE CHAN HENRY | SVP, General Counsel | 31 Jul 2023 | Sale | 791 | 216.2567 | 171,059 | D |
06 Jul 2023 17:02 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 03 Jul 2023 | Sale | 472 | 179.5495 | 84,747 | D |
27 Jun 2023 17:24 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 26 Jun 2023 | Sale | 5 | 183.15 | 916 | D |
27 Jun 2023 17:24 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 26 Jun 2023 | Sale | 1,103 | 181.9144 | 200,652 | D |
27 Jun 2023 17:22 | BGNE | BeiGene Ltd. | WANG JULIA AIJUN | Chief Financial Officer | 23 Jun 2023 | Sale | 840 | 182.85 | 153,594 | D |
27 Jun 2023 17:21 | BGNE | BeiGene Ltd. | SANDERS CORAZON (CORSEE) D. | Director | 23 Jun 2023 | Sale | 478 | 182.6515 | 87,307 | D |
27 Jun 2023 17:21 | BGNE | BeiGene Ltd. | SANDERS CORAZON (CORSEE) D. | Director | 23 Jun 2023 | Sale | 100 | 180.74 | 18,074 | D |
27 Jun 2023 17:20 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 26 Jun 2023 | Sale | 1,495 | 182.365 | 272,636 | D |
20 Jun 2023 18:53 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 20 Jun 2023 | Sale | 1,325 | 192.4192 | 254,955 | D |
15 Jun 2023 19:25 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 14 Jun 2023 | Sale | 273,728 | 207.7171 | 56,857,986 | I |
15 Jun 2023 19:25 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 13 Jun 2023 | Sale | 313,400 | 128.4335 | 40,251,059 | I |
15 Jun 2023 19:25 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 13 Jun 2023 | Sale | 611,000 | 211.4522 | 129,197,294 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 12 Jun 2023 | Sale | 968,812 | 213.9125 | 207,240,997 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 12 Jun 2023 | Sale | 281,400 | 130.8322 | 36,816,181 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 09 Jun 2023 | Sale | 328,952 | 217.0183 | 71,388,604 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 09 Jun 2023 | Sale | 213,700 | 130.3523 | 27,856,287 | I |
12 Jun 2023 21:57 | BGNE | BeiGene Ltd. | HHLR ADVISORS, LTD. | 10% | 08 Jun 2023 | Sale | 1,163,825 | 218.1443 | 253,881,790 | I |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 116 | 226.1511 | 26,234 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 111 | 225.2721 | 25,005 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 161 | 224.0403 | 36,070 | D |
09 Jun 2023 17:46 | BGNE | BeiGene Ltd. | WANG LAI | Global Head of R&D | 07 Jun 2023 | Sale | 74 | 223.2333 | 16,519 | D |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 824 | 226.1511 | 186,349 | D |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 789 | 225.2721 | 177,740 | D |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 1,147 | 224.0403 | 256,974 | D |
09 Jun 2023 17:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 07 Jun 2023 | Sale | 531 | 223.2333 | 118,537 | D |
10 May 2023 16:44 | BGNE | BeiGene Ltd. | WU XIAOBIN | President, COO & GM China | 08 May 2023 | Sale | 7,000 | 253.7196 | 1,776,037 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)